Allogeneic transplant for myeloma in the era of new drugs: have the outcomes improved?

Leuk Lymphoma. 2012 Aug;53(8):1630-2. doi: 10.3109/10428194.2012.656630. Epub 2012 Feb 13.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / therapeutic use
  • Female
  • Humans
  • Male
  • Medical Oncology / methods
  • Melphalan / therapeutic use
  • Middle Aged
  • Multiple Myeloma / mortality
  • Multiple Myeloma / therapy*
  • Risk
  • Stem Cell Transplantation / methods
  • Transplantation Conditioning / methods
  • Transplantation, Homologous
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Melphalan